Daily Temozolomide for Elderly Patients With Unmethylated MGMT- Promoter Newly Diagnosed GliOblatoma
Clinical trial NCT07476794 · RECRUITING
Trial details
- NCT number
- NCT07476794
- Sponsor
- Sunnybrook Health Sciences Centre
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-11-01
- Primary completion
- 2027-10-01
- Enrollment
- 118
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.